152 related articles for article (PubMed ID: 11499485)
1. A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine.
Boulton DW; Markowitz JS; DeVane CL
J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(2):319-23. PubMed ID: 11499485
[TBL] [Abstract][Full Text] [Related]
2. Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection.
Dusci LJ; Peter Hackett L; Fellows LM; Ilett KF
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(2):191-7. PubMed ID: 12031846
[TBL] [Abstract][Full Text] [Related]
3. Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection.
Chiu JA; Franklin RB
J Pharm Biomed Anal; 1996 Mar; 14(5):609-15. PubMed ID: 8738191
[TBL] [Abstract][Full Text] [Related]
4. Fully automated on-line determination of olanzapine in serum for routine therapeutic drug monitoring.
Olesen OV; Poulsen B; Linnet K
Ther Drug Monit; 2001 Feb; 23(1):51-5. PubMed ID: 11206044
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography.
Weigmann H; Härtter S; Maehrlein S; Kiefer W; Krämer G; Dannhardt G; Hiemke C
J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):63-71. PubMed ID: 11499630
[TBL] [Abstract][Full Text] [Related]
6. Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection.
Aravagiri M; Ames D; Wirshing WC; Marder SR
Ther Drug Monit; 1997 Jun; 19(3):307-13. PubMed ID: 9200772
[TBL] [Abstract][Full Text] [Related]
7. Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection.
Bao J; Potts BD
J Chromatogr B Biomed Sci Appl; 2001 Mar; 752(1):61-7. PubMed ID: 11254198
[TBL] [Abstract][Full Text] [Related]
8. Determination of olanzapine in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
D'Arrigo C; Migliardi G; Santoro V; Spina E
Ther Drug Monit; 2006 Jun; 28(3):388-93. PubMed ID: 16778724
[TBL] [Abstract][Full Text] [Related]
9. Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs.
Olesen OV; Linnet K
J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):309-15. PubMed ID: 9766871
[TBL] [Abstract][Full Text] [Related]
10. A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure.
Raggi MA; Casamenti G; Mandrioli R; Volterra V
J Chromatogr B Biomed Sci Appl; 2001 Jan; 750(1):137-46. PubMed ID: 11204214
[TBL] [Abstract][Full Text] [Related]
11. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection.
Catlow JT; Barton RD; Clemens M; Gillespie TA; Goodwin M; Swanson SP
J Chromatogr B Biomed Appl; 1995 Jun; 668(1):85-90. PubMed ID: 7550985
[TBL] [Abstract][Full Text] [Related]
12. Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry.
Berna M; Ackermann B; Ruterbories K; Glass S
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(1):163-8. PubMed ID: 11863288
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a sensitive liquid chromatography/electrospray tandem mass spectrometry assay for the quantification of olanzapine in human plasma.
Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Maurya S; Boosi R; Yerramilli A
J Pharm Biomed Anal; 2006 Jun; 41(3):935-42. PubMed ID: 16504450
[TBL] [Abstract][Full Text] [Related]
14. Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection.
Kasper SC; Mattiuz EL; Swanson SP; Chiu JA; Johnson JT; Garner CO
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):203-9. PubMed ID: 10348187
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of olanzapine in human plasma with reversed-phase high performance liquid chromatography].
Xiao H; Xie SP; Fan JX; Yao H; Han G
Se Pu; 2001 May; 19(3):281-2. PubMed ID: 12541820
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
Bogusz MJ; Krüger KD; Maier RD; Erkwoh R; Tuchtenhagen F
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):257-69. PubMed ID: 10517347
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection.
Zhang G; Terry AV; Bartlett MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):20-8. PubMed ID: 17588832
[TBL] [Abstract][Full Text] [Related]
18. Determination of olanzapine and N-desmethyl-olanzapine in plasma using a reversed-phase HPLC coupled with coulochemical detection: correlation of olanzapine or N-desmethyl-olanzapine concentration with metabolic parameters.
Lu ML; Lin CH; Chen YC; Yang HC; Wu TH
PLoS One; 2013; 8(5):e65719. PubMed ID: 23741510
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid.
Josefsson M; Roman M; Skogh E; Dahl ML
J Pharm Biomed Anal; 2010 Nov; 53(3):576-82. PubMed ID: 20452161
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients.
Bergemann N; Frick A; Parzer P; Kopitz J
Pharmacopsychiatry; 2004 Mar; 37(2):63-8. PubMed ID: 15048613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
